Tracked deals
5
5 tracked deals across 2020-2025.
Plantation, Florida, United States
Formerly known as BioMatrix Infusion, BioMatrix Infusion Pharmacy, BioMatrix Specialty Pharmacy
LUX Infusion is a U.S.-based, clinician-led infusion services company providing home infusion and ambulatory infusion center services, with faster therapy starts and dedicated patient support while sharing continuous data with providers to support adherence and outcomes.
Tracked deals
5
5 tracked deals across 2020-2025.
Recent pace
3
3 tracked deals announced in the last 12 months.
Deal mix
Buyout
5 buyout
Last 3 years
Supporting Data
BioMatrix Infusion Pharmacy acquired First Choice Wellness Centers, LLC (transaction closed December 10, 2025) to expand its ambulatory and home infusion footprint across the Southeast. First Choice operates eleven ambulatory infusion centers across Alabama, Florida, Georgia, Kentucky and Tennessee, bringing referral relationships, patient volume and payer access that support BioMatrix's community-based infusion strategy.
BioMatrix Infusion Pharmacy acquired Total Infusion Care (TIC), a Nevada-based provider of home and ambulatory infusion therapy serving patients across the western United States. The transaction closed on November 7, 2025, and TIC’s Henderson, Nevada location will continue operating as part of the BioMatrix network.
BioMatrix Infusion Pharmacy acquired LUX Infusion, an Alaska-based ambulatory infusion center operator, adding three infusion centers effective October 17, 2025. The deal expands BioMatrix's national ambulatory infusion footprint and integrates LUX's clinical teams and operating model to accelerate growth and extend home infusion nursing into the Pacific Northwest.
BioMatrix Specialty Pharmacy, based in Plantation, Florida, has acquired InfuCare LTD, a home infusion specialty pharmacy in Tyler, Texas. The transaction adds a Texas brick-and-mortar location to BioMatrix's national footprint and expands its infusion capabilities, payer contracts, and access to covered lives for therapies such as IVIG, anti-infectives, and parenteral nutrition.
BioMatrix Specialty Pharmacy has acquired City Drugs Specialty Pharmacy, a specialty pharmacy located on the Upper East Side of Manhattan. The deal expands BioMatrix's national footprint to 12 pharmacy locations and adds payer contracts, clinical staff experienced in rare and chronic conditions, and capabilities across oncology, hepatitis, autoimmune and gastroenterology therapeutic areas.
Turn tracked acquisition activity into an outreach-ready buyer list.